Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension

By Thomas G. Neil  

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 131-155

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-pill Fixed-dose Combination of Valsartan and Amlodipine

By Miura S   Saku K  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite

Biased Agonism of the Angiotensin II Type 1 Receptor

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 812-816

Bentham Science Publishers

Access to resources Recommend Favorite

Antiproteinuric Effect of Angiotensin-converting Enzyme Inhibitors and an Angiotensin II Receptor Blocker in Patients with Lupus Nephritis

By Kitamura N   Matsukawa Y   Takei M   Sawada S  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 892-898

Field House Publishing

Access to resources Recommend Favorite